Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer

Withdrawn before enrolling · Not applicable

Conditions studied: Fallopian Tube Carcinoma, Ovarian Carcinoma

In brief

This pilot clinical trial studies how well photoacoustic imaging works in detecting ovarian or fallopian tube cancer. Photoacoustic imaging is an imaging method that uses lasers to light up tissue, and then converts the light information into ultrasound images. Photoacoustic imaging can provide images of the structure of tissues, as well as their function and the levels of molecules, such as the flow of blood in blood vessels and the level of oxygen in the blood. Photoacoustic imaging may help doctors determine whether a mass is benign (non-cancerous) or cancerous based on the molecular differences between cancer and normal tissue. It may be more accurate and less expensive than other imaging methods, and does not expose patients to radiation.

Key facts

Study ID

NCT02530606

Run by

Stanford University

People needed

0

Starts

2016-09-01

Expected to finish

2018-11-01

Last updated by the study team

2018-11-28

Who can join

Age: 18 and older, up to 80. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients must be undergoing ovarian resection
• Ability to understand and the willingness to sign a written informed consent document

You may not qualify if…

• Patients who have had primary surgical excision
• Pregnant or lactating women

Where it is running

• Stanford University, School of Medicine — Palo Alto, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.